Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2019-05-08 AGM Information
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
CellaVision AB: Kommuniké från årsstämma i CellaVision AB (publ) den 8 maj, 2019
AGM Information Classification · 1% confidence The document title explicitly states "Årsstämma i CellaVision AB (publ) den 8 maj 2019" which translates to "Annual General Meeting in CellaVision AB (publ) on May 8, 2019". The content details decisions made at this meeting, including the approval of financial statements, dividend declaration, election/re-election of board members and chairman, approval of board and auditor remuneration, and approval of executive compensation guidelines. These are all core components of an Annual General Meeting (AGM) process. Therefore, the classification is AGM-R.
2019-05-08 Swedish
CellaVision AB: Bulletin from AGM held on May 8, 2019
AGM Information Classification · 1% confidence The document explicitly states it covers the 'Annual General Meeting of CellaVision AB (publ) on May 8, 2019'. It details resolutions passed at this meeting, including the approval of financial statements, dividend declaration, board elections, director fees, and auditor appointment. These elements are characteristic of the formal proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2019-05-08 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-March 2019. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, regional growth, and innovation. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-07 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January-March 2019' and contains comprehensive financial statements, including income statements, cash flow analysis, and detailed management commentary on performance, market development, and risks for the first quarter of 2019. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-07 English
Annual Report 2018
Annual Report Classification · 1% confidence The document is titled 'CELLAVISION ÅRSREDOVISNING 2018' (Annual Report 2018). It contains comprehensive financial statements, management's discussion and analysis (VD-ord), board information, and detailed operational reports for the fiscal year 2018. It is clearly a full annual report, not an announcement or a summary. FY 2018
2019-04-10 Swedish
Annual Report 2018
Annual Report Classification · 1% confidence The document is explicitly titled 'CELLAVISION ANNUAL REPORT 2018'. It contains a comprehensive table of contents, financial summaries, CEO comments, strategic agendas, and audited financial statements (Group and Parent company). It is a full-length annual report, not an announcement or a summary, and meets the criteria for a 10-K equivalent (Annual Report). FY 2018
2019-04-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.